已核实 DOI PubMed 相关产品: 14

Inhibition and Mechanism of Protein Nonenzymatic Glycation by Lactobacillus fermentum

Journal 2024 · IF 4.7 · 13(8): 1183 · 发表于 2024 年 4 月 12 日
作者: Qin Li,Ke Xiao,Chi Yi,Fan Yu,Wenyue Wang,Junhui Rao,Menglin Liu,Lin Zhang,Yang Mu,Chao Wang,Qian Wu,Dongsheng Li,Mengzhou Zhou
阅读全文 在 PubMed 查看

摘要

Lactobacillus fermentum(L. fermentum) was first evaluated as a potential advanced glycation end-product (AGE) formation inhibitor by establishing a bovine serum albumin (BSA) + glucose (glu) glycation model in the present study. The results showed that the highest inhibition rates of pentosidine and total fluorescent AGEs byL. fermentumwere approximately 51.67% and 77.22%, respectively, which were higher than that of aminoguanidine (AG). Mechanistic analysis showed thatL. fermentumcould capture methylglyoxal and glyoxal, inhibit carbonyl and sulfhydryl oxidation, reduce the binding of glucose and amino groups, increase total phenolic content and antioxidant activity, and release intracellular substances to scavenge free radicals; these abilities were the basis of the antiglycation mechanism ofL. fermentum. In addition,L. fermentumsignificantly prevented conformational changes in proteins during glycation, reduced protein cross-linking by 35.67%, and protected the intrinsic fluorophore. Therefore, the inhibition ofL. fermentumon glycation mainly occurs through antioxidation, the capture of dicarbonyl compounds, and the protection of the BSA structure. These findings collectively suggest thatLactobacillusis an inhibitor of protein glycation and AGE formation and has the potential for nutraceutical applications.

本研究中使用的阿拉丁产品

14 款产品在本文中被引用